Artículos de revistas sobre el tema "Strophanthinum"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 45 mejores artículos de revistas para su investigación sobre el tema "Strophanthinum".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Shah, Yatin. "Strophanthin – ein besonderes Herzglykosid". Zeitschrift für Komplementärmedizin 3, n.º 02 (abril de 2011): 48–51. http://dx.doi.org/10.1055/s-0030-1270928.
Texto completoSchmidramsi, H., B. Ostermayr y J. v. Arnim. "Proving of g-strophanthin". British Homoeopathic journal 82, n.º 4 (octubre de 1993): 269. http://dx.doi.org/10.1016/s0007-0785(05)80679-9.
Texto completoTsyvunin, V. V., S. Yu Shtrygol, D. V. Shtrygol y D. P. Kavraiskyi. "Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study". Acta Medica Leopoliensia 27, n.º 1-2 (junio de 2021): 63–69. http://dx.doi.org/10.25040/aml2021.01-02.063.
Texto completoVilensky, L. "Strofantin and novazurol for heart disease". Kazan medical journal 20, n.º 9 (11 de agosto de 2021): 990–91. http://dx.doi.org/10.17816/kazmj77072.
Texto completoMcKenzie, A. G. "The rise and fall of strophanthin". International Congress Series 1242 (diciembre de 2002): 95–100. http://dx.doi.org/10.1016/s0531-5131(02)00729-x.
Texto completoDadashyan, A. M. "Experience in the use of convallotoxin in circulatory failure". Kazan medical journal 43, n.º 5 (16 de noviembre de 2021): 52–53. http://dx.doi.org/10.17816/kazmj87787.
Texto completoFrost, Jørgen y Erik Warburg. "Clinical experiences concerning the effect of strophanthin". Acta Medica Scandinavica 130, S206 (24 de abril de 2009): 132–44. http://dx.doi.org/10.1111/j.0954-6820.1948.tb12030.x.
Texto completoIonova, E. O., I. A. Miroshkina, A. V. Sorokina y S. A. Kryzhanovskii. "Comparative evaluation of echocardiographic and morphometric characteristics of the rat heart left ventricle". Pharmacokinetics and Pharmacodynamics, n.º 1 (10 de mayo de 2023): 41–44. http://dx.doi.org/10.37489/2587-7836-2023-1-41-44.
Texto completoGrosa, Giorgio, Gianna Allegrone y Erika Del Grosso. "LC–ESI-MS/MS characterization of strophanthin-K". Journal of Pharmaceutical and Biomedical Analysis 38, n.º 1 (junio de 2005): 79–86. http://dx.doi.org/10.1016/j.jpba.2004.12.008.
Texto completoOlesin, A. I., I. V. Konstantinova, N. N. Tyuteleva y V. S. Ivanov. "Clinical and prognostic significance of left ventricular dysfunction predictors in patients with ventricular ectopy and without structural heart disease". Fundamental and Clinical Medicine 8, n.º 3 (29 de septiembre de 2023): 53–67. http://dx.doi.org/10.23946/2500-0764-2023-8-3-53-67.
Texto completoArnim, H. Schmidramsl; B. Ostermayr; J. v. "g-Strophanthin - Ergebnisse von 2 Arzneimittelprüfungen mit der 4. Dezimalpotenz". Allgemeine Homöopathische Zeitung 238, n.º 03 (4 de abril de 2007): 106–9. http://dx.doi.org/10.1055/s-2006-936451.
Texto completoChekman, I. S., N. A. Gorchakova, V. V. Bratus' y I. S. Mudraya. "Combined inotropic effect of strophanthin and calcium on heart muscle". Bulletin of Experimental Biology and Medicine 99, n.º 3 (marzo de 1985): 317–20. http://dx.doi.org/10.1007/bf00799077.
Texto completoGalenko-Yaroshevskii, P. A., S. M. Lemkina y Ya V. Kostin. "Drug correction of impaired strophanthin tolerance during simulated cardiac decompensation". Bulletin of Experimental Biology and Medicine 117, n.º 5 (mayo de 1994): 483–86. http://dx.doi.org/10.1007/bf02444295.
Texto completoBogus, Saida K., Pavel A. Galenko-Yaroshevsky, Konstantin F. Suzdalev, Galina V. Sukoyan y Valery G. Abushkevich. "2-phenyl-1-(3-pyrrolidin-1-il-propyl)-1 H-indole hydrochloride (SS-68): Antiarrhythmic and cardioprotective activity and its molecular mechanisms of action (Part I)". Research Results in Pharmacology 4, n.º 1 (31 de agosto de 2018): 130–55. http://dx.doi.org/10.3897/rrpharmacology.4.28592.
Texto completoTawfik, Hoda, Alanna A. L. Fox y Kurt Greeff. "Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides". Biochemical Pharmacology 34, n.º 14 (julio de 1985): 2541–47. http://dx.doi.org/10.1016/0006-2952(85)90540-4.
Texto completoKarsanov, N. V., G. V. Sukoyan, D. R. Tatulashvili, V. N. Karsanov y L. D. Mamulashvili. "Difference between mechanisms of action ofβ-acetyldigoxin, strophanthin K, and ouabain". Bulletin of Experimental Biology and Medicine 113, n.º 2 (febrero de 1992): 186–89. http://dx.doi.org/10.1007/bf00791495.
Texto completoKrupin, Theodore, Lisa F. Rosenberg, Arnold L. Sandridge, Charles J. Bock, Adrienne Berman y Jon M. Ruderman. "Effects of Topical K-Strophanthin on Aqueous Humor and Corneal Dynamics". Journal of Glaucoma 4, n.º 5 (octubre de 1995): 327???333. http://dx.doi.org/10.1097/00061198-199510000-00006.
Texto completoZENG, YONG-CHUN, ZHENG-JUN JIN y PEI-KUN GU. "Retinal Toxicity in Albino Rabbits Induced by Intravitreal Injection of Strophanthin-K". Journal of Ocular Pharmacology and Therapeutics 6, n.º 1 (enero de 1990): 51–60. http://dx.doi.org/10.1089/jop.1990.6.51.
Texto completoSobieva, Z. I., M. N. Karpova y E. G. Kryzhanovskaya. "Effect of lithium compounds on cardiac arrhythmias induced by strophanthin in conscious rats". Bulletin of Experimental Biology and Medicine 99, n.º 4 (abril de 1985): 410–13. http://dx.doi.org/10.1007/bf00842725.
Texto completoKudryavtseva, N. P., V. I. Kachurets y S. X. Nasibullina. "The use of strophanthin in the complex treatment of cardiovascular disorders in toxic diphtheria". Kazan medical journal 43, n.º 3 (29 de octubre de 2021): 42–43. http://dx.doi.org/10.17816/kazmj83692.
Texto completoÖSTLING, GUSTAF. "The Significance of the Speed of Injection for the Therapeutic Effect of K-Strophanthin". Acta Medica Scandinavica 129, n.º 1 (24 de abril de 2009): 77–80. http://dx.doi.org/10.1111/j.0954-6820.1947.tb09286.x.
Texto completoGuang-tian, Yang y S. Daum. "Wirkung von Strophanthin, Digoxin und Isoproterenol auf die Herzkontraktilität während Hypoxie und hyperkapnischer Azidose". Journal of Tongji Medical University 6, n.º 4 (diciembre de 1986): 199–205. http://dx.doi.org/10.1007/bf02909745.
Texto completoSergeev, P. V., P. A. Galenko-Yaroshevskii, S. M. Lemkina y Ya V. Kostin. "Comparative evaluation of pharmacological effects of combined application of strophanthin with some antiadrenergic agents". Bulletin of Experimental Biology and Medicine 119, n.º 5 (mayo de 1995): 484–87. http://dx.doi.org/10.1007/bf02543436.
Texto completoPogorelova, V. N., A. I. Panait y A. G. Pogorelov. "Nonspecific effect of Na+/K+-ATPase inhibition with strophanthin or under hypothermia in rat heart". Biophysics 59, n.º 5 (septiembre de 2014): 768–71. http://dx.doi.org/10.1134/s0006350914050212.
Texto completoRajabzoda, M. M. "Consequences of road transportation accidents, their standard growth, modern management and tactics of treatment of victims". Health care of Tajikistan, n.º 2 (21 de julio de 2022): 82–87. http://dx.doi.org/10.52888/0514-2515-2022-353-2-83-88.
Texto completoBauer, N., G. Scheiner-Bobis y W. Schoner. "„Endogenes Digitalis” – der lange Weg vom herzwirksamen pflanzlichen Toxin zum Hormon der Säuger". Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 34, n.º 06 (2006): 389–97. http://dx.doi.org/10.1055/s-0037-1622553.
Texto completoSørensen, Else Vigholt y Folmer Nielsen-Kudsk. "Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart". European Journal of Pharmacology 125, n.º 3 (junio de 1986): 363–71. http://dx.doi.org/10.1016/0014-2999(86)90792-2.
Texto completoMikhailov, I. B. "Effect of strophanthin and digoxin on activity of an experimental epileptogenic focus in the frog hippocampus". Bulletin of Experimental Biology and Medicine 104, n.º 5 (noviembre de 1987): 1572–74. http://dx.doi.org/10.1007/bf00845084.
Texto completoFazulzyanov, A. A., V. M. Andreev y G. N. Fazulzyanova. "Respiratory mechanics, alveolar ventilation, ventilation-perfusion relations in the correction of heart failure with strophanthin and kapoten". Kazan medical journal 76, n.º 6 (15 de noviembre de 1995): 417–19. http://dx.doi.org/10.17816/kazmj90429.
Texto completoBonah, Christian. "‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)". History and Technology 29, n.º 2 (junio de 2013): 135–52. http://dx.doi.org/10.1080/07341512.2013.833039.
Texto completoHassan, A. B., M. Atef y I. M. Shihata. "Effect of Digoxin and Strophanthin on Renal Blood Flow and Systemic Blood Pressure in Normal and Bled Dogs". Zentralblatt für Veterinärmedizin Reihe A 26, n.º 2 (13 de mayo de 2010): 152–58. http://dx.doi.org/10.1111/j.1439-0442.1979.tb00660.x.
Texto completoGalenko-Yaroshevskii, P. A., S. M. Lemkina y Ya V. Kostin. "Effects of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacological effects of strophanthinin vivo andin vitro". Bulletin of Experimental Biology and Medicine 117, n.º 1 (enero de 1994): 61–64. http://dx.doi.org/10.1007/bf02444082.
Texto completoKarsanov, N. V., T. N. Macharashvili y V. A. Magaldadze. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the contractile protein system of normal cardiomyocytes". Bulletin of Experimental Biology and Medicine 108, n.º 6 (diciembre de 1989): 1735–38. http://dx.doi.org/10.1007/bf00841047.
Texto completoGalenko-Yaroshevskii, P. A., S. M. Lernkina y Ya V. Kostin. "Correction with cordarone of changes in cathepsin D activity induced by modeled circulation insufficiency and toxic action of strophanthin K". Bulletin of Experimental Biology and Medicine 122, n.º 4 (octubre de 1996): 1005–7. http://dx.doi.org/10.1007/bf02447021.
Texto completoGalenko-Yaroshevskii, P. A., S. M. Lemkina y Ya V. Kostin. "Correction of altered β-glucosidase activity induced by the toxic effect of strophanthin K and modeled cardiac decompensation with cordaron". Bulletin of Experimental Biology and Medicine 121, n.º 6 (junio de 1996): 581–83. http://dx.doi.org/10.1007/bf02447123.
Texto completoKarsanov, N. V., V. A. Magaldadze y T. N. Macharashvili. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the myocardial contractile protein system in toxico-allergic cardiomyopathy". Bulletin of Experimental Biology and Medicine 111, n.º 5 (mayo de 1991): 698–700. http://dx.doi.org/10.1007/bf00841022.
Texto completoAgostoni, Pier Giuseppe, Elisabetta Doria, Marco Berti y Maurizio D. Guazzi. "Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: A double-blind crossover evaluation versus digoxin". Clinical Cardiology 17, n.º 10 (octubre de 1994): 536–41. http://dx.doi.org/10.1002/clc.4960171005.
Texto completoKrvavych, Anna y Roksolana Konechna. "Optimization of parameters of the extraction process of biologically active substances of grass Adonis vernalis". Technology audit and production reserves 3, n.º 3(59) (2 de julio de 2021): 14–18. http://dx.doi.org/10.15587/2706-5448.2021.235471.
Texto completoGalust'yan, G. �. y I. B. Mikhailov. "Effect of strophanthin and digoxin on succinate and lactate dehydrogenase and membrane Na+, K+-ATPase activity in the heart of rats with experimental myocarditis". Bulletin of Experimental Biology and Medicine 107, n.º 4 (abril de 1989): 498–500. http://dx.doi.org/10.1007/bf00842388.
Texto completoDanielopolu, D., Marin Popescu y Gr Gr Popa. "Action of Drugs on Cholinesterase and on the Adrenolytic Factors. Inactivating Action of Eserine, Strophanthin and Ascorbic Acid on Cholinesterase and on the Adrenolytic Factors." Acta Pharmacologica et Toxicologica 4, n.º 3-4 (13 de marzo de 2009): 339–50. http://dx.doi.org/10.1111/j.1600-0773.1948.tb03356.x.
Texto completoDatté, J. Y. y A. Ziegler. "Pharmacological investigation on nigrescigenin-a cardenolide fromParquetina nigrescens(Afzel.) Bullock: comparative studies on cardiotonic effects ofParquetina nigrescens, g-strophanthin and noradrenaline in guinea-pig isolated atria". Journal of Pharmacy and Pharmacology 53, n.º 6 (junio de 2001): 859–66. http://dx.doi.org/10.1211/0022357011776018.
Texto completoSugimoto, Jiro, Seiichi Yuasa y Masayasu Suzuki. "Comparison of Effects of Alprenolol, Carteolol, Indenolol, Pindolol, Practolol, and Propranolol in Relation to their Beta-Blocking, Local Anaesthetic, Membrane Stabilizing, and Strophanthin-G Cardiotoxicity Antagonizing Actions in Guinea-Pig". Journal of Kansai Medical University 39, n.º 4 (1987): 418–29. http://dx.doi.org/10.5361/jkmu1956.39.4_418.
Texto completoDoepp, Manfred. "May Strophanthin be a valuable cardiac drug ?" American Journal of Medical and Clinical Research & Reviews 02, n.º 09 (2023). http://dx.doi.org/10.58372/2835-6276.1069.
Texto completo"Die Lösung des Herzinfarkt-Problems durch g-Strophanthin". Erfahrungsheilkunde 53, n.º 02 (febrero de 2004): 65–73. http://dx.doi.org/10.1055/s-2004-819994.
Texto completoSharma, Ashish Kumar, Shivam Singh, Mehvish Bhat, Kartik Gill, Mohammad Zaid, Sachin Kumar, Anjali Shakya et al. "New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models". Scientific Reports 13, n.º 1 (29 de septiembre de 2023). http://dx.doi.org/10.1038/s41598-023-41942-4.
Texto completo